Amanda Ferdinand

Amanda Ferdinand is an experienced scientist who specializes in assay development and compound profiling. Amanda has worked at Cancer Research Technology and currently works at Cancer Research Horizons. Amanda's research background includes investigating erythroid enucleation during their PhD at the University of Bristol. Amanda also gained valuable skills in neurodegeneration research during a placement at Eli Lilly and Company. Amanda holds a PhD in Cell/Cellular and Molecular Biology from the University of Bristol and a Bachelor of Science in Biochemistry from the University of Bath.